Persist Ai Raises $4M In Seed Financing, Rapidly Accelerates Drug Formulation
08/04/23, 12:06 PM
Location
woodlandMoney raised
$4 million
Industry
healthcare
Round Type
seed
Investors
Pioneer Fund, Y Combinator, Fellows Fund, Innospark Ventures, 2048 Ventures
Persist AI, the AI-driven pioneer in drug formulation, announced today the close of an oversubscribed $4M financing round following their completion of YCombinator, the prestigious San Francisco based startup accelerator. The funding round was led by 2048 Ventures with the participation of Innospark Ventures, Fellows Fund, YCombinator, Pioneer Fund, and others.
Company Info
Location
1100 main street
woodland, california, united states
Additional Info
Developing extended-release PLG drug formulations takes $10M+ and 5-10 years. We enable drug manufacturers and CROs to shorten formulation discovery time by 30-50% by utilizing our automation and machine learning platform.